dacarbazine has been researched along with Argentaffinoma in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonodimitrakis, P; Crona, J; Eriksson, B; Fanola, I; Granberg, D; Lindholm, DP; Öberg, K | 1 |
| Sands, MJ; Wunderle, KA | 1 |
| Abbasi, S; Albaba, H; Kashashna, A | 1 |
| Baudin, E; Caplin, ME; Ferolla, P; Filosso, P; Garcia-Yuste, M; Lim, E; Oberg, K; Pelosi, G; Perren, A; Rossi, RE; Travis, WD | 1 |
| Chen, H; Gill, H; Lubner, S; Matsumura, JB; Somnay, Y | 1 |
| Clark, JW; Enzinger, PC; Frauenhoffer, C; Fuchs, CS; Hooshmand, S; Hornick, JL; Kulke, MH; Meyerhardt, JA; Redston, MS; Ryan, DP; Stuart, K | 1 |
| Couvelard, A; Faivre, S; Hammel, P; Hentic, O; Larroque, B; Lévy, P; Maire, F; Raymond, E; Ruszniewski, P; Yapur, L; Zappa, M | 1 |
| Bodoky, G; Pregun, I; Rácz, K; Tulassay, Z | 1 |
| Reidy-Lagunes, D; Thornton, R | 1 |
| Faivre, S; Hammel, P; Hentic, O; Neuzillet, C; Raymond, E; Ruszniewski, P | 1 |
| Clark, JW; Enzinger, PC; Fuchs, CS; Kulke, MH; Michelini, A; Muzikansky, A; Ryan, DP; Stuart, K; Vincitore, M | 1 |
| Dunder, K; Ekeblad, S; Eriksson, B; Granberg, D; Janson, ET; Kindmark, H; Kozlovacki, G; Oberg, K; Orlefors, H; Sigurd, M; Skogseid, B; Sundin, A; Welin, S | 1 |
| Moertel, CG | 1 |
| Foley, JF; Kessinger, A; Lemon, HM | 1 |
| Moertel, CG; Rubin, J; van Hazel, GA | 1 |
| Leonhardt, U; Ramadori, G; Ritzel, U; Stöckmann, F | 1 |
| Bukowski, RM; Eyre, HJ; Fleming, TR; Macdonald, JS; Peterson, RF; Rinehart, JJ; Rivkin, SE; Tangen, CM; Taylor, SA | 1 |
| Bécouarn, Y; Brunet, R; Fonck, M; Ollivier, S | 1 |
| Altimari, AF; Badrinath, K; Prinz, RA; Reisel, HJ | 1 |
| Buck, M; Kvols, LK | 1 |
6 review(s) available for dacarbazine and Argentaffinoma
| Article | Year |
|---|---|
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Dacarbazine; Etoposide; Europe; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Receptors, Somatostatin; Societies, Medical; Temozolomide; Tomography, X-Ray Computed; Ultrasonography | 2015 |
[Carcinoid tumors].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biomarkers, Tumor; Bronchial Neoplasms; Carcinoid Tumor; Chromogranin A; Clinical Trials as Topic; Dacarbazine; Early Detection of Cancer; Gastrointestinal Neoplasms; Heterocyclic Compounds; Humans; Hydroxyindoleacetic Acid; Lung Neoplasms; Organometallic Compounds; Prevalence; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Somatostatin; Temozolomide; Thalidomide; TOR Serine-Threonine Kinases; Treatment Outcome | 2010 |
Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different?
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoid Tumor; Combined Modality Therapy; Dacarbazine; Embolization, Therapeutic; Everolimus; Humans; Immunosuppressive Agents; Indoles; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sirolimus; Streptozocin; Sunitinib; Temozolomide; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factors; Yttrium Radioisotopes | 2012 |
New treatment options with cytotoxic agents in neuroendocrine tumours.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carcinoid Tumor; Clinical Trials as Topic; Cytotoxins; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Medical Oncology; Neuroendocrine Tumors; Quality of Life; Streptozocin; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2012 |
Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Carcinoid Tumor; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Embolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Ligation; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Middle Aged; Rectal Neoplasms; Streptozocin; Tamoxifen | 1983 |
Chemotherapy of metastatic carcinoid and islet cell tumors. A review.
Topics: Adenoma, Islet Cell; Antineoplastic Agents; Carcinoid Tumor; Dacarbazine; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Neoplasm Metastasis; Pancreatic Neoplasms; Streptozocin | 1987 |
3 trial(s) available for dacarbazine and Argentaffinoma
| Article | Year |
|---|---|
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma, Islet Cell; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pheochromocytoma; Survival Analysis; Temozolomide; Thalidomide; Treatment Outcome | 2006 |
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasm Metastasis | 1994 |
Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Dacarbazine; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Survival Rate | 1998 |
11 other study(ies) available for dacarbazine and Argentaffinoma
| Article | Year |
|---|---|
Effect of temozolomide in patients with metastatic bronchial carcinoids.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bronchial Neoplasms; Carcinoid Tumor; Cohort Studies; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Temozolomide; Young Adult | 2013 |
Radiation recall after a transarterial hepatic chemoembolization.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoid Tumor; Chemoembolization, Therapeutic; Dacarbazine; Deoxycytidine; Drug Administration Schedule; Fluoroscopy; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Radiodermatitis; Radiography, Interventional; Risk Factors; Temozolomide; Time Factors | 2014 |
Efficacy of capecitabine and temozolomide combination in well-differentiated neuroendocrine tumors: Jordan experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoid Tumor; Cell Differentiation; Dacarbazine; Deoxycytidine; Developing Countries; Disease-Free Survival; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Jordan; Male; Middle Aged; Neuroendocrine Tumors; Remission Induction; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome | 2014 |
The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.
Topics: Benzimidazoles; Biomarkers, Tumor; Carcinoid Tumor; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Humans; Neoplasm Metastasis; Phenotype; Poly(ADP-ribose) Polymerase Inhibitors | 2016 |
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.
Topics: Antineoplastic Agents, Alkylating; Carcinoid Tumor; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; O(6)-Methylguanine-DNA Methyltransferase; Pancreatic Neoplasms; Temozolomide; Treatment Outcome | 2009 |
Temozolomide: a safe and effective treatment for malignant digestive endocrine tumors.
Topics: Aged; Analysis of Variance; Antineoplastic Agents, Alkylating; Carcinoid Tumor; Dacarbazine; Digestive System Neoplasms; Disease Progression; Endocrine Gland Neoplasms; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Temozolomide; Time Factors; Treatment Outcome | 2009 |
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
Topics: Aged; Bronchial Neoplasms; Carcinoid Tumor; Dacarbazine; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Temozolomide; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Therapy of malignant APUD cell tumors. Effectiveness of DTIC.
Topics: Adenoma, Islet Cell; Adult; Aged; Apudoma; Carcinoid Tumor; Carcinoma; Dacarbazine; Female; Humans; Ileal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Thyroid Neoplasms | 1983 |
Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine.
Topics: Adult; Aged; Carcinoid Tumor; Dacarbazine; Dactinomycin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies | 1983 |
Treatment of metastasized midgut carcinoids with dacarbazine.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoid Tumor; Dacarbazine; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Infusions, Intravenous; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Treatment Outcome | 1995 |
DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.
Topics: Abdominal Neoplasms; Adenoma, Islet Cell; Adult; Animals; Carcinoid Tumor; Dacarbazine; Female; Glucagonoma; Humans; Ileal Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Retroperitoneal Neoplasms | 1987 |